165 related articles for article (PubMed ID: 34287294)
21. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
[TBL] [Abstract][Full Text] [Related]
22. Identification of herpes zoster high-risk group using Charlson comorbidity index: A nationwide retrospective cohort study.
Cho SI; Lee DH; Park YM
J Dermatol; 2020 Jan; 47(1):47-53. PubMed ID: 31642113
[TBL] [Abstract][Full Text] [Related]
23. Herpes zoster and postherpetic neuralgia.
Johnson RW
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
[TBL] [Abstract][Full Text] [Related]
24. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
[TBL] [Abstract][Full Text] [Related]
25. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care network.
Sun X; Wei Z; Lin H; Jit M; Li Z; Fu C
J Infect; 2021 Feb; 82(2):253-260. PubMed ID: 33359014
[TBL] [Abstract][Full Text] [Related]
26. A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China.
Suo L; Lu L; Li J; Sun M; Wang H; Peng X; Yang F; Pang X; Marin M; Wang C
BMC Infect Dis; 2017 May; 17(1):334. PubMed ID: 28486993
[TBL] [Abstract][Full Text] [Related]
27. Association between the Risk of Relapse and the Type of Surgical Procedure for Herpes Zoster-related Pain.
Luo G; Zhang Z; Zhu J; Xie K; Ni H; Tao J; Yao M
Pain Physician; 2021 Dec; 24(8):E1227-1236. PubMed ID: 34793649
[TBL] [Abstract][Full Text] [Related]
28. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
[TBL] [Abstract][Full Text] [Related]
30. Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live.
Bruxvoort KJ; Liang AS; Harpaz R; Qian L; Sy LS; LaRussa P; Schmid DS; Luo Y; Takhar H; Tseng HF
Vaccine; 2019 Jun; 37(26):3478-3484. PubMed ID: 31088744
[TBL] [Abstract][Full Text] [Related]
31. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
[TBL] [Abstract][Full Text] [Related]
32. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
33. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
Klein NP; Bartlett J; Fireman B; Marks MA; Hansen J; Lewis E; Aukes L; Saddier P
Vaccine; 2019 Aug; 37(36):5422-5427. PubMed ID: 31301920
[TBL] [Abstract][Full Text] [Related]
34. Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.
Liu YC; Yang YH; Hsiao HH; Yang WC; Liu TC; Chang CS; Yang MY; Lin PM; Hsu JF; Chang PY; Lin SF
BMC Cancer; 2012 Oct; 12():503. PubMed ID: 23114019
[TBL] [Abstract][Full Text] [Related]
35. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster.
Park SY; Kim JY; Kwon JS; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2019 Nov; 91(11):1995-2000. PubMed ID: 31286531
[TBL] [Abstract][Full Text] [Related]
36. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
[TBL] [Abstract][Full Text] [Related]
37. Management of herpes zoster (shingles) and postherpetic neuralgia.
Johnson RW; Whitton TL
Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
[TBL] [Abstract][Full Text] [Related]
38. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of herpes zoster and postherpetic neuralgia].
Hüning S; von Dücker L; Kohl WK; Nashan D
Hautarzt; 2019 Aug; 70(8):645-656. PubMed ID: 31270550
[TBL] [Abstract][Full Text] [Related]
40. Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: A register-based population study.
Chawki S; Vilcu AM; Etienne C; Finet F; Blanchon T; Souty C; Hanslik T
J Infect; 2022 Apr; 84(4):531-536. PubMed ID: 35016899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
